> 0 1 0 1 O
1.5 2 5 2 5 B-lower_bound
cm2 6 9 6 9 I-lower_bound
residual 10 18 10 18 B-chronic_disease
disease 19 26 19 26 I-chronic_disease
following 27 36 27 36 O
resection 37 46 37 46 O
for 47 50 47 50 O
any 51 54 51 54 O
Medulloblastoma 55 70 55 70 B-cancer
histology 71 80 71 80 O

Active 0 6 81 87 O
, 6 7 87 88 O
uncontrolled 8 20 89 101 B-chronic_disease
infection 21 30 102 111 I-chronic_disease
and/or 31 37 112 118 O
HIV 38 41 119 122 B-chronic_disease
positive 42 50 123 131 O

Active 0 6 132 138 O
, 6 7 138 139 O
uncontrolled 8 20 140 152 O
infection 21 30 153 162 B-chronic_disease
and/or 31 37 163 169 O
human 38 43 170 175 B-chronic_disease
immunodeficiency 44 60 176 192 I-chronic_disease
virus 61 66 193 198 I-chronic_disease
( 67 68 199 200 I-chronic_disease
HIV 68 71 200 203 I-chronic_disease
) 71 72 203 204 I-chronic_disease
positive 73 81 205 213 O
constitute 82 92 214 224 O
progressive 93 104 225 236 B-chronic_disease
disease 105 112 237 244 I-chronic_disease

Age 0 3 245 248 B-age
12 4 6 249 251 B-lower_bound
- 6 7 251 252 O
18 7 9 252 254 B-upper_bound
months 10 16 255 261 I-upper_bound
( 17 18 262 263 O
365 18 21 263 266 B-lower_bound
- 21 22 266 267 O
547 22 25 267 270 B-upper_bound
days 26 30 271 275 I-upper_bound
) 30 31 275 276 O
with 32 36 277 281 O
any 37 40 282 285 O
of 41 43 286 288 O
the 44 47 289 292 O
following 48 57 293 302 O
3 58 59 303 304 O
unfavorable 60 71 305 316 O
biologic 72 80 317 325 O
features 81 89 326 334 O
( 90 91 335 336 O
MYCN 91 95 336 340 B-clinical_variable
amplification 96 109 341 354 I-clinical_variable
, 109 110 354 355 O
unfavorable 111 122 356 367 O
pathology 123 132 368 377 O
and/or 133 139 378 384 O
DNA 140 143 385 388 B-clinical_variable
index 144 149 389 394 I-clinical_variable
= 150 151 395 396 O
1 152 153 397 398 O
) 153 154 398 399 O
or 155 157 400 402 O
any 158 161 403 406 O
biologic 162 170 407 415 O
feature 171 178 416 423 O
that 179 183 424 428 O
is 184 186 429 431 O
indeterminate 187 200 432 445 O
/ 200 201 445 446 O
unsatisfactory 201 215 446 460 O
/ 215 216 460 461 O
unknown 216 223 461 468 O

Age 0 3 469 472 B-age
> 4 5 473 474 O
18 6 8 475 477 B-lower_bound
months 9 15 478 484 I-lower_bound
( 16 17 485 486 O
> 17 18 486 487 O
547 19 22 488 491 B-lower_bound
days 23 27 492 496 I-lower_bound
) 27 28 496 497 O
regardless 29 39 498 508 O
of 40 42 509 511 O
biologic 43 51 512 520 O
features 52 60 521 529 O

Age 0 3 530 533 B-age
> 4 5 534 535 O
18 6 8 536 538 B-lower_bound
months 9 15 539 545 I-lower_bound
( 16 17 546 547 O
> 17 18 547 548 O
547 19 22 549 552 B-lower_bound
days 23 27 553 557 I-lower_bound
) 27 28 557 558 O
with 29 33 559 563 O
unfavorable 34 45 564 575 O
pathology 46 55 576 585 O
, 55 56 585 586 O
regardless 57 67 587 597 O
of 68 70 598 600 O
MYCN 71 75 601 605 O
status 76 82 606 612 O

Age 0 3 613 616 B-age
and 4 7 617 620 O
Performance 8 19 621 632 O
Status 20 26 633 639 O
, 26 27 639 640 O
Arm 28 31 641 644 O
A 32 33 645 646 O

Age 0 3 647 650 B-age
and 4 7 651 654 O
Performance 8 19 655 666 B-clinical_variable
Status 20 26 667 673 I-clinical_variable
, 26 27 673 674 O
Arm 28 31 675 678 O
B 32 33 679 680 O

Age 0 3 681 684 B-age
and 4 7 685 688 O
Performance 8 19 689 700 B-clinical_variable
Status 20 26 701 707 I-clinical_variable
, 26 27 707 708 O
Arm 28 31 709 712 O
C 32 33 713 714 O

Age 0 3 715 718 B-age
and 4 7 719 722 O
Performance 8 19 723 734 B-clinical_variable
Status 20 26 735 741 I-clinical_variable
, 26 27 741 742 O
Arm 28 31 743 746 O
D 32 33 747 748 O

Age 0 3 749 752 B-age
and 4 7 753 756 O
Performance 8 19 757 768 B-clinical_variable
Status 20 26 769 775 I-clinical_variable
, 26 27 775 776 O
Arm 28 31 777 780 O
E 32 33 781 782 O

Age 0 3 783 786 B-age
: 3 4 786 787 O
0 5 6 788 789 B-lower_bound
- 7 8 790 791 O
70 9 11 792 794 B-upper_bound
years 12 17 795 800 I-upper_bound

Age 0 3 801 804 B-age
: 3 4 804 805 O
0 5 6 806 807 B-lower_bound
- 6 7 807 808 O
70 7 9 808 810 B-upper_bound
years 10 15 811 816 I-upper_bound
of 16 18 817 819 O
age 19 22 820 823 B-age

Age 0 3 824 827 B-age
: 3 4 827 828 O
Patients 5 13 829 837 O
must 14 18 838 842 O
be 19 21 843 845 O
≤ 22 23 846 847 O
30 24 26 848 850 B-upper_bound
years 27 32 851 856 I-upper_bound
of 33 35 857 859 O
age 36 39 860 863 B-age
at 40 42 864 866 O
the 43 46 867 870 O
time 47 51 871 875 O
of 52 54 876 878 O
initial 55 62 879 886 O
diagnosis 63 72 887 896 O

All 0 3 897 900 O
patients 4 12 901 909 O
must 13 17 910 914 O
have 18 22 915 919 O
histological 23 35 920 932 O
verification 36 48 933 945 O
of 49 51 946 948 O
malignancy 52 62 949 959 B-cancer
at 63 65 960 962 O
original 66 74 963 971 O
diagnosis 75 84 972 981 O

Anaplastic 0 10 982 992 B-clinical_variable
Histologic 11 21 993 1003 I-clinical_variable
Variant 22 29 1004 1011 I-clinical_variable
Medulloblastoma 30 45 1012 1027 I-clinical_variable
: 45 46 1027 1028 O
less 47 51 1029 1033 O
than 52 56 1034 1038 O
70 57 59 1039 1041 B-upper_bound
years 60 65 1042 1047 I-upper_bound
of 66 68 1048 1050 O
age 69 72 1051 1054 B-age
, 72 73 1054 1055 O
any 74 77 1056 1059 O
metastatic 78 88 1060 1070 O
stage 89 94 1071 1076 O
, 94 95 1076 1077 O
with 96 100 1078 1082 O
total 101 106 1083 1088 O
or 107 109 1089 1091 O
sub 110 113 1092 1095 O
- 113 114 1095 1096 O
total 114 119 1096 1101 O
resection 120 129 1102 1111 O

Arm 0 3 1112 1115 O
A 4 5 1116 1117 O
: 5 6 1117 1118 O
Solid 7 12 1119 1124 O
Tumor 13 18 1125 1130 B-cancer

Arm 0 3 1131 1134 O
B 4 5 1135 1136 O
: 5 6 1136 1137 O
Certain 7 14 1138 1145 O
CNS 15 18 1146 1149 B-cancer
tumors 19 25 1150 1156 I-cancer

Arm 0 3 1157 1160 O
C 4 5 1161 1162 O
: 5 6 1162 1163 O
Evidence 7 15 1164 1172 O
of 16 18 1173 1175 O
progressive 19 30 1176 1187 O
or 31 33 1188 1190 O
recurrent 34 43 1191 1200 O
GCT 44 47 1201 1204 B-cancer
( 48 49 1205 1206 O
measurable 49 59 1206 1216 O
or 60 62 1217 1219 O
non 63 66 1220 1223 O
- 66 67 1223 1224 O
measurable 67 77 1224 1234 O
) 77 78 1234 1235 O
following 79 88 1236 1245 O
one 89 92 1246 1249 O
or 93 95 1250 1252 O
more 96 100 1253 1257 O
cisplatin 101 110 1258 1267 O
- 110 111 1267 1268 O
based 111 116 1268 1273 O
chemotherapy 117 129 1274 1286 B-treatment

Arm 0 3 1287 1290 O
C 4 5 1291 1292 O
: 5 6 1292 1293 O
Germ 7 11 1294 1298 B-chronic_disease
Cell 12 16 1299 1303 I-chronic_disease
Tumors 17 23 1304 1310 I-chronic_disease

Arm 0 3 1311 1314 O
D 4 5 1315 1316 O
: 5 6 1316 1317 O
Certain 7 14 1318 1325 O
CNS 15 18 1326 1329 B-cancer
Tumor 19 24 1330 1335 I-cancer
patients 25 33 1336 1344 O
who 34 37 1345 1348 O
can 38 41 1349 1352 O
only 42 46 1353 1357 O
undergo 47 54 1358 1365 O
one 55 58 1366 1369 O
transplant 59 69 1370 1380 B-treatment

Arm 0 3 1381 1384 O
E 4 5 1385 1386 O
: 5 6 1386 1387 O
Neuroblastoma 7 20 1388 1401 B-cancer

Arm 0 3 1402 1405 O
E 4 5 1406 1407 O
: 5 6 1407 1408 O
Pregnant 7 15 1409 1417 B-pregnancy
or 16 18 1418 1420 O
breastfeeding 19 32 1421 1434 O

Atypical 0 8 1435 1443 B-cancer
Teratoid 9 17 1444 1452 I-cancer
/ 17 18 1452 1453 I-cancer
Rhabdoid 18 26 1453 1461 I-cancer
Tumor 27 32 1462 1467 I-cancer
( 33 34 1468 1469 I-cancer
AT 34 36 1469 1471 I-cancer
/ 36 37 1471 1472 I-cancer
RT 37 39 1472 1474 I-cancer
): 39 41 1474 1476 I-cancer
less 42 46 1477 1481 O
than 47 51 1482 1486 O
70 52 54 1487 1489 B-upper_bound
years 55 60 1490 1495 I-upper_bound
of 61 63 1496 1498 O
age 64 67 1499 1502 B-age
with 68 72 1503 1507 O
CNS 73 76 1508 1511 B-cancer
AT 77 79 1512 1514 I-cancer
/ 79 80 1514 1515 I-cancer
RT 80 82 1515 1517 I-cancer
( 83 84 1518 1519 O
with 84 88 1519 1523 O
or 89 91 1524 1526 O
without 92 99 1527 1534 O
metastatic 100 110 1535 1545 B-cancer
disease 111 118 1546 1553 I-cancer
) 118 119 1553 1554 O

CNS 0 3 1555 1558 B-cancer
Lymphoma 4 12 1559 1567 I-cancer
- 13 14 1568 1569 O
primary 15 22 1570 1577 B-cancer
or 23 25 1578 1580 I-cancer
secondary 26 35 1581 1590 I-cancer
CNS 36 39 1591 1594 I-cancer
lymphoma 40 48 1595 1603 I-cancer

Camera 0 6 1604 1610 O
method 7 13 1611 1617 O
is 14 16 1618 1620 O
NOT 17 20 1621 1624 O
allowed 21 28 1625 1632 O
as 29 31 1633 1635 O
measure 32 39 1636 1643 O
of 40 42 1644 1646 O
GFR 43 46 1647 1650 B-clinical_variable
prior 47 52 1651 1656 O
to 53 55 1657 1659 O
or 56 58 1660 1662 O
during 59 65 1663 1669 O
Consolidation 66 79 1670 1683 B-treatment
therapy 80 87 1684 1691 I-treatment
for 88 91 1692 1695 O
patients 92 100 1696 1704 O
with 101 105 1705 1709 O
GFR 106 109 1710 1713 O
or 110 112 1714 1716 O
creatinine 113 123 1717 1727 B-clinical_variable
clearance 124 133 1728 1737 I-clinical_variable
of 134 136 1738 1740 O
< 137 138 1741 1742 O
100 139 142 1743 1746 B-upper_bound
ml 143 145 1747 1749 I-upper_bound
/ 145 146 1749 1750 I-upper_bound
min/1.73m2 146 156 1750 1760 I-upper_bound
. 156 157 1760 1761 O
) 157 158 1761 1762 O

Cardiac 0 7 1763 1770 O
: 7 8 1770 1771 O
ejection 9 17 1772 1780 B-clinical_variable
fraction 18 26 1781 1789 I-clinical_variable
≥ 27 28 1790 1791 O
45 29 31 1792 1794 B-lower_bound
% 31 32 1794 1795 I-lower_bound
or 33 35 1796 1798 O
no 36 38 1799 1801 O
clinical 39 47 1802 1810 O
evidence 48 56 1811 1819 O
of 57 59 1820 1822 O
heart 60 65 1823 1828 B-chronic_disease
failure 66 73 1829 1836 I-chronic_disease

Children 0 8 1837 1845 O
less 9 13 1846 1850 O
than 14 18 1851 1855 O
36 19 21 1856 1858 B-upper_bound
months 22 28 1859 1865 I-upper_bound
( 29 30 1866 1867 I-upper_bound
3 30 31 1867 1868 I-upper_bound
years 32 37 1869 1874 I-upper_bound
) 37 38 1874 1875 I-upper_bound
of 39 41 1876 1878 O
age 42 45 1879 1882 B-age
at 46 48 1883 1885 O
time 49 53 1886 1890 O
of 54 56 1891 1893 O
definitive 57 67 1894 1904 O
surgery 68 75 1905 1912 B-treatment
( 76 77 1913 1914 O
for 77 80 1914 1917 O
histopathologic 81 96 1918 1933 O
diagnosis 97 106 1934 1943 O
) 106 107 1943 1944 O
who 108 111 1945 1948 O
have 112 116 1949 1953 O
high 117 121 1954 1958 O
risk 122 126 1959 1963 O
Medulloblastoma 127 142 1964 1979 B-cancer

Children 0 8 1980 1988 O
less 9 13 1989 1993 O
than 14 18 1994 1998 O
36 19 21 1999 2001 B-upper_bound
months 22 28 2002 2008 I-upper_bound
( 29 30 2009 2010 I-upper_bound
3 30 31 2010 2011 I-upper_bound
years 32 37 2012 2017 I-upper_bound
) 37 38 2017 2018 I-upper_bound
of 39 41 2019 2021 O
age 42 45 2022 2025 B-age
at 46 48 2026 2028 O
time 49 53 2029 2033 O
of 54 56 2034 2036 O
definitive 57 67 2037 2047 O
surgery 68 75 2048 2055 B-treatment
( 76 77 2056 2057 O
for 77 80 2057 2060 O
histopathologic 81 96 2061 2076 O
diagnosis 97 106 2077 2086 O
) 106 107 2086 2087 O
with 108 112 2088 2092 O
or 113 115 2093 2095 O
without 116 123 2096 2103 O
metastatic 124 134 2104 2114 B-cancer
disease 135 142 2115 2122 I-cancer

Children 0 8 2123 2131 O
less 9 13 2132 2136 O
than 14 18 2137 2141 O
8 19 20 2142 2143 B-upper_bound
months 21 27 2144 2150 I-upper_bound
of 28 30 2151 2153 O
age 31 34 2154 2157 B-age
at 35 37 2158 2160 O
the 38 41 2161 2164 O
time 42 46 2165 2169 O
of 47 49 2170 2172 O
definitive 50 60 2173 2183 B-treatment
surgery 61 68 2184 2191 I-treatment
( 69 70 2192 2193 O
for 70 73 2193 2196 O
histopathologic 74 89 2197 2212 O
diagnosis 90 99 2213 2222 O
) 99 100 2222 2223 O
, 100 101 2223 2224 O
any 102 105 2225 2228 O
histology 106 115 2229 2238 O
, 115 116 2238 2239 O
any 117 120 2240 2243 O
metastatic 121 131 2244 2254 B-cancer
state 132 137 2255 2260 O
, 137 138 2260 2261 O
with 139 143 2262 2266 O
total 144 149 2267 2272 O
or 150 152 2273 2275 O
sub 153 156 2276 2279 O
- 156 157 2279 2280 O
total 157 162 2280 2285 O
resection 163 172 2286 2295 B-treatment

Concomitant 0 11 2296 2307 O
enrollment 12 22 2308 2318 O
on 23 25 2319 2321 O
clinical 26 34 2322 2330 B-treatment
study 35 40 2331 2336 I-treatment
( 41 42 2337 2338 O
such 42 46 2338 2342 O
as 47 49 2343 2345 O
COG 50 53 2346 2349 O
study 54 59 2350 2355 O
) 59 60 2355 2356 O
that 61 65 2357 2361 O
does 66 70 2362 2366 O
not 71 74 2367 2370 O
allow 75 80 2371 2376 O
co 81 83 2377 2379 O
- 83 84 2379 2380 O
enrollment 84 94 2380 2390 O
on 95 97 2391 2393 O
this 98 102 2394 2398 O
standard 103 111 2399 2407 B-treatment
of 112 114 2408 2410 I-treatment
care 115 119 2411 2415 I-treatment
protocol 120 128 2416 2424 I-treatment
( 129 130 2425 2426 O
Arm 130 133 2426 2429 O
B 134 135 2430 2431 O
only 136 140 2432 2436 O
) 140 141 2436 2437 O

Confirmation 0 12 2438 2450 O
of 13 15 2451 2453 O
germ 16 20 2454 2458 B-cancer
cell 21 25 2459 2463 I-cancer
tumor 26 31 2464 2469 I-cancer
( 32 33 2470 2471 I-cancer
GCT 33 36 2471 2474 I-cancer
) 36 37 2474 2475 I-cancer
histology 38 47 2476 2485 O
( 48 49 2486 2487 O
both 49 53 2487 2491 O
seminoma 54 62 2492 2500 B-cancer
and 63 66 2501 2504 O
nonseminoma 67 78 2505 2516 B-cancer
) 78 79 2516 2517 O

Consecutive 0 11 2518 2529 O
elevated 12 20 2530 2538 O
serum 21 26 2539 2544 B-clinical_variable
tumor 27 32 2545 2550 I-clinical_variable
markers 33 40 2551 2558 I-clinical_variable
( 41 42 2559 2560 O
HCG 42 45 2560 2563 B-clinical_variable
or 46 48 2564 2566 O
AFP 49 52 2567 2570 B-clinical_variable
) 52 53 2570 2571 O
that 54 58 2572 2576 O
are 59 62 2577 2580 O
increasing 63 73 2581 2591 O

Ewing 0 5 2592 2597 B-cancer
's 5 7 2597 2599 I-cancer
Family 8 14 2600 2606 I-cancer
Tumors 15 21 2607 2613 I-cancer
( 22 23 2614 2615 O
ES 23 25 2615 2617 B-cancer
/ 25 26 2617 2618 O
PNET 26 30 2618 2622 B-cancer
/ 30 31 2622 2623 O
DSRCT 31 36 2623 2628 B-cancer
) 36 37 2628 2629 O
- 38 39 2630 2631 O
metastatic 40 50 2632 2642 B-cancer
at 51 53 2643 2645 O
time 54 58 2646 2650 O
of 59 61 2651 2653 O
diagnosis 62 71 2654 2663 O
and/or 72 78 2664 2670 O
relapsed 79 87 2671 2679 O
after 88 93 2680 2685 B-treatment
therapy 94 101 2686 2693 I-treatment

Examples 0 8 2694 2702 O
of 9 11 2703 2705 O
contraindications 12 29 2706 2723 O
might 30 35 2724 2729 O
be 36 38 2730 2732 O
a 39 40 2733 2734 O
weight 41 47 2735 2741 B-clinical_variable
or 48 50 2742 2744 O
size 51 55 2745 2749 O
less 56 60 2750 2754 O
than 61 65 2755 2759 O
that 66 70 2760 2764 O
determined 71 81 2765 2775 O
to 82 84 2776 2778 O
be 85 87 2779 2781 O
feasible 88 96 2782 2790 O
at 97 99 2791 2793 O
the 100 103 2794 2797 O
collecting 104 114 2798 2808 O
institution 115 126 2809 2820 O
, 126 127 2820 2821 O
or 128 130 2822 2824 O
a 131 132 2825 2826 O
physical 133 141 2827 2835 O
condition 142 151 2836 2845 O
that 152 156 2846 2850 O
would 157 162 2851 2856 O
limit 163 168 2857 2862 O
the 169 172 2863 2866 O
ability 173 180 2867 2874 O
of 181 183 2875 2877 O
the 184 187 2878 2881 O
child 188 193 2882 2887 O
to 194 196 2888 2890 O
undergo 197 204 2891 2898 O
apheresis 205 214 2899 2908 B-treatment
catheter 215 223 2909 2917 I-treatment
placement 224 233 2918 2927 I-treatment
( 234 235 2928 2929 O
if 235 237 2929 2931 O
necessary 238 247 2932 2941 O
) 247 248 2941 2942 O
and/or 249 255 2943 2949 O
the 256 259 2950 2953 O
apheresis 260 269 2954 2963 O
procedure 270 279 2964 2973 O

Hematologic 0 11 2974 2985 B-chronic_disease
: 11 12 2985 2986 O
ANC 13 16 2987 2990 B-clinical_variable
> 17 18 2991 2992 O
750 19 22 2993 2996 B-lower_bound
/ 22 23 2996 2997 I-lower_bound
μl 23 25 2997 2999 I-lower_bound
, 25 26 2999 3000 O
hemoglobin 27 37 3001 3011 B-clinical_variable
of 38 40 3012 3014 O
> 41 42 3015 3016 O
8 42 43 3016 3017 B-lower_bound
gm 44 46 3018 3020 I-lower_bound
/ 46 47 3020 3021 I-lower_bound
dl 47 49 3021 3023 I-lower_bound
( 50 51 3024 3025 O
may 51 54 3025 3028 O
receive 55 62 3029 3036 O
PRBC 63 67 3037 3041 B-treatment
transfusions 68 80 3042 3054 I-treatment
) 80 81 3054 3055 O
and 82 85 3056 3059 O
platelet 86 94 3060 3068 B-clinical_variable
count 95 100 3069 3074 I-clinical_variable
> 101 102 3075 3076 O
75,000 103 109 3077 3083 B-lower_bound
/ 109 110 3083 3084 I-lower_bound
μl 110 112 3084 3086 I-lower_bound
( 113 114 3087 3088 O
transfusion 114 125 3088 3099 O
independent 126 137 3100 3111 O
) 137 138 3111 3112 O

Hematologic 0 11 3113 3124 B-chronic_disease
: 11 12 3124 3125 O
ANC 13 16 3126 3129 B-clinical_variable
≥ 17 18 3130 3131 O
750 19 22 3132 3135 B-lower_bound
/ 22 23 3135 3136 I-lower_bound
mm3 23 26 3136 3139 I-lower_bound
, 26 27 3139 3140 O
platelets 28 37 3141 3150 B-clinical_variable
≥ 38 39 3151 3152 O
75,000 40 46 3153 3159 B-lower_bound
/ 46 47 3159 3160 I-lower_bound
mm3 47 50 3160 3163 I-lower_bound

Hematologic 0 11 3164 3175 B-chronic_disease
: 11 12 3175 3176 O
hemoglobin 13 23 3177 3187 B-clinical_variable
of 24 26 3188 3190 O
> 27 28 3191 3192 O
9 28 29 3192 3193 B-lower_bound
gm 30 32 3194 3196 I-lower_bound
/ 32 33 3196 3197 I-lower_bound
dl 33 35 3197 3199 I-lower_bound
and 36 39 3200 3203 O
platelet 40 48 3204 3212 B-clinical_variable
count 49 54 3213 3218 I-clinical_variable
> 55 56 3219 3220 O
20,000 57 63 3221 3227 B-lower_bound
/ 63 64 3227 3228 I-lower_bound
μl 64 66 3228 3230 I-lower_bound

Hepatic 0 7 3231 3238 O
: 7 8 3238 3239 O
AST 9 12 3240 3243 B-clinical_variable
< 13 14 3244 3245 O
3 15 16 3246 3247 B-upper_bound
x 17 18 3248 3249 I-upper_bound
upper 19 24 3250 3255 I-upper_bound
normal 25 31 3256 3262 I-upper_bound

Hepatic 0 7 3263 3270 O
: 7 8 3270 3271 O
AST 9 12 3272 3275 B-clinical_variable
or 13 15 3276 3278 O
ALT 16 19 3279 3282 B-clinical_variable
≤ 20 21 3283 3284 O
2.5 22 25 3285 3288 B-upper_bound
x 26 27 3289 3290 I-upper_bound
ULN 28 31 3291 3294 I-upper_bound
and 32 35 3295 3298 O
bilirubin 36 45 3299 3308 B-clinical_variable
≤ 46 47 3309 3310 O
1.5 48 51 3311 3314 B-upper_bound
x 52 53 3315 3316 I-upper_bound
ULN 54 57 3317 3320 I-upper_bound

Hepatic 0 7 3321 3328 B-chronic_disease
: 7 8 3328 3329 O
AST 9 12 3330 3333 B-clinical_variable
or 13 15 3334 3336 O
ALT 16 19 3337 3340 B-clinical_variable
≤ 20 21 3341 3342 O
2.5 22 25 3343 3346 B-upper_bound
x 26 27 3347 3348 I-upper_bound
upper 28 33 3349 3354 I-upper_bound
limits 34 40 3355 3361 I-upper_bound
of 41 43 3362 3364 I-upper_bound
normal 44 50 3365 3371 I-upper_bound
( 51 52 3372 3373 I-upper_bound
ULN 52 55 3373 3376 I-upper_bound
) 55 56 3376 3377 I-upper_bound
, 56 57 3377 3378 O
if 58 60 3379 3381 O
hepatic 61 68 3382 3389 O
involvement 69 80 3390 3401 O
< 81 82 3402 3403 O
5 83 84 3404 3405 B-upper_bound
x 85 86 3406 3407 I-upper_bound
ULN 87 90 3408 3411 I-upper_bound
; 90 91 3411 3412 O
bilirubin 92 101 3413 3422 B-clinical_variable
≤ 102 103 3423 3424 O
2.0 104 107 3425 3428 B-upper_bound
x 108 109 3429 3430 I-upper_bound
upper 110 115 3431 3436 I-upper_bound
limits 116 122 3437 3443 I-upper_bound
of 123 125 3444 3446 I-upper_bound
normal 126 132 3447 3453 I-upper_bound
( 133 134 3454 3455 I-upper_bound
ULN 134 137 3455 3458 I-upper_bound
) 137 138 3458 3459 I-upper_bound

Hepatic 0 7 3460 3467 O
: 7 8 3467 3468 O
AST 9 12 3469 3472 B-clinical_variable
or 13 15 3473 3475 O
ALT 16 19 3476 3479 B-clinical_variable
≤ 20 21 3480 3481 O
5 22 23 3482 3483 B-upper_bound
x 24 25 3484 3485 I-upper_bound
ULN 26 29 3486 3489 B-clinical_variable
and 30 33 3490 3493 O
bilirubin 34 43 3494 3503 B-clinical_variable
≤ 44 45 3504 3505 O
5 46 47 3506 3507 O
x 48 49 3508 3509 O
ULN 50 53 3510 3513 O

Hepatoblastoma 0 14 3514 3528 B-cancer
- 15 16 3529 3530 O
metastatic 17 27 3531 3541 O
at 28 30 3542 3544 O
time 31 35 3545 3549 O
of 36 38 3550 3552 O
diagnosis 39 48 3553 3562 O
and/or 49 55 3563 3569 O
relapsed 56 64 3570 3578 O
after 65 70 3579 3584 O
therapy 71 78 3585 3592 O

Increase 0 8 3593 3601 O
of 9 11 3602 3604 O
an 12 14 3605 3607 O
elevated 15 23 3608 3616 O
LDH 24 27 3617 3620 B-treatment
alone 28 33 3621 3626 O
does 34 38 3627 3631 O
not 39 42 3632 3635 O
constitute 43 53 3636 3646 O
progressive 54 65 3647 3658 B-chronic_disease
disease 66 73 3659 3666 I-chronic_disease

Infant 0 6 3667 3673 O
Medulloblastoma 7 22 3674 3689 B-cancer

Infant 0 6 3690 3696 O
Medulloblastoma 7 22 3697 3712 B-cancer
: 22 23 3712 3713 O
Children 24 32 3714 3722 O
less 33 37 3723 3727 O
than 38 42 3728 3732 O
8 43 44 3733 3734 B-upper_bound
months 45 51 3735 3741 I-upper_bound
of 52 54 3742 3744 O
age 55 58 3745 3748 B-age
at 59 61 3749 3751 O
the 62 65 3752 3755 O
time 66 70 3756 3760 O
of 71 73 3761 3763 O
definitive 74 84 3764 3774 B-treatment
surgery 85 92 3775 3782 I-treatment
( 93 94 3783 3784 O
for 94 97 3784 3787 O
histopathologic 98 113 3788 3803 O
diagnosis 114 123 3804 3813 O
) 123 124 3813 3814 O
, 124 125 3814 3815 O
any 126 129 3816 3819 O
histology 130 139 3820 3829 O
, 139 140 3829 3830 O
any 141 144 3831 3834 O
metastatic 145 155 3835 3845 O
state 156 161 3846 3851 O
, 161 162 3851 3852 O
with 163 167 3853 3857 O
total 168 173 3858 3863 O
or 174 176 3864 3866 O
sub 177 180 3867 3870 O
- 180 181 3870 3871 O
total 181 186 3871 3876 O
resection 187 196 3877 3886 B-treatment

Karnofsky 0 9 3887 3896 B-clinical_variable
Performance 10 21 3897 3908 I-clinical_variable
Status 22 28 3909 3915 I-clinical_variable
≥ 29 30 3916 3917 O
50 31 33 3918 3920 B-lower_bound
% 33 34 3920 3921 I-lower_bound
for 35 38 3922 3925 O
patients 39 47 3926 3934 O
> 48 49 3935 3936 O
16 50 52 3937 3939 B-lower_bound
years 53 58 3940 3945 I-lower_bound
of 59 61 3946 3948 O
age 62 65 3949 3952 B-age

Karnofsky 0 9 3953 3962 B-clinical_variable
Performance 10 21 3963 3974 I-clinical_variable
Status 22 28 3975 3981 I-clinical_variable
≥ 29 30 3982 3983 O
70 31 33 3984 3986 B-lower_bound
% 33 34 3986 3987 I-lower_bound
for 35 38 3988 3991 O
patients 39 47 3992 4000 O
> 48 49 4001 4002 O
16 50 52 4003 4005 B-lower_bound
years 53 58 4006 4011 I-lower_bound
of 59 61 4012 4014 O
age 62 65 4015 4018 B-age

Known 0 5 4019 4024 O
contraindication 6 22 4025 4041 O
to 23 25 4042 4044 O
PBSC 26 30 4045 4049 B-allergy_name
collection 31 41 4050 4060 I-allergy_name

Lansky 0 6 4061 4067 B-clinical_variable
Play 7 11 4068 4072 I-clinical_variable
Score 12 17 4073 4078 I-clinical_variable
≥ 18 19 4079 4080 O
50 20 22 4081 4083 B-lower_bound
for 23 26 4084 4087 O
patients 27 35 4088 4096 O
≤ 36 37 4097 4098 O
16 38 40 4099 4101 B-upper_bound
years 41 46 4102 4107 I-upper_bound
of 47 49 4108 4110 O
age 50 53 4111 4114 B-age

Lansky 0 6 4115 4121 B-clinical_variable
Play 7 11 4122 4126 I-clinical_variable
Score 12 17 4127 4132 I-clinical_variable
≥ 18 19 4133 4134 O
70 20 22 4135 4137 B-lower_bound
for 23 26 4138 4141 O
patients 27 35 4142 4150 O
≤ 36 37 4151 4152 O
16 38 40 4153 4155 B-upper_bound
years 41 46 4156 4161 I-upper_bound
of 47 49 4162 4164 O
age 50 53 4165 4168 B-age

MRI 0 3 4169 4172 B-treatment
evidence 4 12 4173 4181 O

MYCN 0 4 4182 4186 B-clinical_variable
amplification 5 18 4187 4200 I-clinical_variable
( 19 20 4201 4202 O
> 20 21 4202 4203 O
4 22 23 4204 4205 B-lower_bound
- 23 24 4205 4206 O
fold 24 28 4206 4210 O
increase 29 37 4211 4219 O
in 38 40 4220 4222 O
MYCN 41 45 4223 4227 O
signals 46 53 4228 4235 O
as 54 56 4236 4238 O
compared 57 65 4239 4247 O
to 66 68 4248 4250 O
reference 69 78 4251 4260 O
signals 79 86 4261 4268 O
) 86 87 4268 4269 O
, 87 88 4269 4270 O
regardless 89 99 4271 4281 O
of 100 102 4282 4284 O
age 103 106 4285 4288 O
or 107 109 4289 4291 O
additional 110 120 4292 4302 O
biologic 121 129 4303 4311 O
features 130 138 4312 4320 O

Medulloblastoma 0 15 4321 4336 B-cancer

Minimum 0 7 4337 4344 O
frozen 8 14 4345 4351 O
PBSC 15 19 4352 4356 B-clinical_variable
of 20 22 4357 4359 O
4 23 24 4360 4361 O
x 25 26 4362 4363 O
106 27 30 4364 4367 O
CD34 31 35 4368 4372 O
cells 36 41 4373 4378 O
/ 41 42 4378 4379 O
kg 42 44 4379 4381 O
as 45 47 4382 4384 O
2 48 49 4385 4386 O
aliquots 50 58 4387 4395 O
; 58 59 4395 4396 O
i.e. 60 64 4397 4401 O
2 65 66 4402 4403 O
x 67 68 4404 4405 O
106 69 72 4406 4409 O
CD34 73 77 4410 4414 O
cells 78 83 4415 4420 O
/ 83 84 4420 4421 O
kg 84 86 4421 4423 O
for 87 90 4424 4427 O
each 91 95 4428 4432 O
transplant 96 106 4433 4443 B-treatment
are 107 110 4444 4447 O
mandatory 111 120 4448 4457 O

Neuroblastoma 0 13 4458 4471 B-cancer
( 14 15 4472 4473 O
ICD 15 18 4473 4476 O
- 18 19 4476 4477 O
O 19 20 4477 4478 O
morphology 21 31 4479 4489 O
9500/3 32 38 4490 4496 O
) 38 39 4496 4497 O
or 40 42 4498 4500 O
ganglioneuroblastoma 43 63 4501 4521 B-cancer
( 64 65 4522 4523 O
nodular 65 72 4523 4530 O
or 73 75 4531 4533 O
intermixed 76 86 4534 4544 O
) 86 87 4544 4545 O
verified 88 96 4546 4554 O
by 97 99 4555 4557 O
histology 100 109 4558 4567 O
or 110 112 4568 4570 O
demonstration 113 126 4571 4584 O
of 127 129 4585 4587 O
clumps 130 136 4588 4594 O
of 137 139 4595 4597 O
tumor 140 145 4598 4603 B-cancer
cells 146 151 4604 4609 I-cancer
in 152 154 4610 4612 O
bone 155 159 4613 4617 O
marrow 160 166 4618 4624 O
with 167 171 4625 4629 O
elevated 172 180 4630 4638 O
urinary 181 188 4639 4646 B-treatment
catecholamine 189 202 4647 4660 I-treatment
metabolites 203 214 4661 4672 I-treatment

Neurologic 0 10 4673 4683 B-chronic_disease
deficits 11 19 4684 4692 I-chronic_disease
in 20 22 4693 4695 O
patients 23 31 4696 4704 O
with 32 36 4705 4709 O
CNS 37 40 4710 4713 B-cancer
tumors 41 47 4714 4720 I-cancer
must 48 52 4721 4725 O
be 53 55 4726 4728 O
stable 56 62 4729 4735 O
for 63 66 4736 4739 O
a 67 68 4740 4741 O
minimum 69 76 4742 4749 O
of 77 79 4750 4752 O
1 80 81 4753 4754 B-upper_bound
week 82 86 4755 4759 I-upper_bound
prior 87 92 4760 4765 I-upper_bound
to 93 95 4766 4768 O
study 96 101 4769 4774 O
entry 102 107 4775 4780 O

No 0 2 4781 4783 O
evidence 3 11 4784 4792 O
of 12 14 4793 4795 O
disease 15 22 4796 4803 B-chronic_disease
progression 23 34 4804 4815 I-chronic_disease
: 34 35 4815 4816 O
defined 36 43 4817 4824 O
as 44 46 4825 4827 O
increase 47 55 4828 4836 O
in 56 58 4837 4839 O
tumor 59 64 4840 4845 B-cancer
size 65 69 4846 4850 O
of 70 72 4851 4853 O
> 73 74 4854 4855 O
25 74 76 4855 4857 B-lower_bound
% 76 77 4857 4858 I-lower_bound
or 78 80 4859 4861 O
new 81 84 4862 4865 O
lesions 85 92 4866 4873 O

One 0 3 4874 4877 B-lower_bound
or 4 6 4878 4880 O
more 7 11 4881 4885 O
unfavorable 12 23 4886 4897 O
prognostic 24 34 4898 4908 O
features 35 43 4909 4917 O
for 44 47 4918 4921 O
achieving 48 57 4922 4931 O
a 58 59 4932 4933 O
CR 60 62 4934 4936 O
with 63 67 4937 4941 O
conventional 68 80 4942 4954 B-treatment
- 80 81 4954 4955 I-treatment
dose 81 85 4955 4959 I-treatment
chemotherapy 86 98 4960 4972 I-treatment

Organ 0 5 4973 4978 O
Function 6 14 4979 4987 O
, 14 15 4987 4988 O
Arm 16 19 4989 4992 O
C 20 21 4993 4994 O
( 22 23 4995 4996 O
to 23 25 4996 4998 O
begin 26 31 4999 5004 O
TI 32 34 5005 5007 B-treatment
chemotherapy 35 47 5008 5020 I-treatment
) 47 48 5020 5021 O

Other 0 5 5022 5027 O
High 6 10 5028 5032 O
Risk 11 15 5033 5037 O
CNS 16 19 5038 5041 B-cancer
Tumors 20 26 5042 5048 I-cancer
- 27 28 5049 5050 O
to 29 31 5051 5053 O
be 32 34 5054 5056 O
approved 35 43 5057 5065 O
by 44 46 5066 5068 O
2 47 48 5069 5070 B-lower_bound
or 49 51 5071 5073 O
more 52 56 5074 5078 O
physicians 57 67 5079 5089 O
( 68 69 5090 5091 O
at 69 71 5091 5093 O
least 72 77 5094 5099 O
one 78 81 5100 5103 B-lower_bound
oncologist 82 92 5104 5114 O
and 93 96 5115 5118 O
one 97 100 5119 5122 O
BMT 101 104 5123 5126 O
physician 105 114 5127 5136 O
) 114 115 5136 5137 O

Other 0 5 5138 5143 O
High 6 10 5144 5148 O
Risk 11 15 5149 5153 O
Metastatic 16 26 5154 5164 B-cancer
or 27 29 5165 5167 O
Relapsed 30 38 5168 5176 B-cancer
Solid 39 44 5177 5182 I-cancer
Tumors 45 51 5183 5189 I-cancer
- 52 53 5190 5191 O
to 54 56 5192 5194 O
be 57 59 5195 5197 O
approved 60 68 5198 5206 O
by 69 71 5207 5209 O
2 72 73 5210 5211 B-lower_bound
or 74 76 5212 5214 O
more 77 81 5215 5219 O
pediatric 82 91 5220 5229 O
hematology 92 102 5230 5240 O
/ 102 103 5240 5241 O
oncology 103 111 5241 5249 O
and 112 115 5250 5253 O
bone 116 120 5254 5258 B-treatment
marrow 121 127 5259 5265 I-treatment
transplant 128 138 5266 5276 I-treatment
( 139 140 5277 5278 I-treatment
BMT 140 143 5278 5281 I-treatment
) 143 144 5281 5282 I-treatment
physicians 145 155 5283 5293 O

PD 0 2 5294 5296 O
after 3 8 5297 5302 O
a 9 10 5303 5304 O
conventional 11 23 5305 5317 B-treatment
- 23 24 5317 5318 I-treatment
dose 24 28 5318 5322 I-treatment
salvage 29 36 5323 5330 I-treatment
( 37 38 5331 5332 O
cisplatin 38 47 5332 5341 B-treatment
+ 48 49 5342 5343 O
ifosfamide 50 60 5344 5354 B-treatment
-based 61 67 5355 5361 O
) 67 68 5361 5362 O
regimen 69 76 5363 5370 O

PD 0 2 5371 5373 O
following 3 12 5374 5383 O
an 13 15 5384 5386 O
incomplete 16 26 5387 5397 O
response 27 35 5398 5406 O
( 36 37 5407 5408 O
IR 37 39 5408 5410 B-treatment
) 39 40 5410 5411 O
to 41 43 5412 5414 O
first 44 49 5415 5420 B-treatment
- 49 50 5420 5421 I-treatment
line 50 54 5421 5425 I-treatment
therapy 55 62 5426 5433 I-treatment

Patients 0 8 5434 5442 O
may 9 12 5443 5446 O
receive 13 20 5447 5454 O
transfusions 21 33 5455 5467 B-treatment
as 34 36 5468 5470 O
necessary 37 46 5471 5480 O

Patients 0 8 5481 5489 O
that 9 13 5490 5494 O
are 14 17 5495 5498 O
12 18 20 5499 5501 B-lower_bound
- 20 21 5501 5502 O
18 21 23 5502 5504 B-upper_bound
months 24 30 5505 5511 I-upper_bound
of 31 33 5512 5514 O
age 34 37 5515 5518 B-age
with 38 42 5519 5523 O
INSS 43 47 5524 5528 B-clinical_variable
Stage 48 53 5529 5534 I-clinical_variable
4 54 55 5535 5536 I-clinical_variable
and 56 59 5537 5540 O
all 60 63 5541 5544 O
3 64 65 5545 5546 O
favorable 66 75 5547 5556 O
biologic 76 84 5557 5565 O
features 85 93 5566 5574 O
( 94 95 5575 5576 O
ie 95 97 5576 5578 O
, 97 98 5578 5579 O
non- 99 103 5580 5584 O
amplified 104 113 5585 5594 O
MYCN 114 118 5595 5599 O
, 118 119 5599 5600 O
favorable 120 129 5601 5610 O
pathology 130 139 5611 5620 O
, 139 140 5620 5621 O
and 141 144 5622 5625 O
DNA 145 148 5626 5629 B-clinical_variable
index 149 154 5630 5635 I-clinical_variable
> 155 156 5636 5637 O
1 157 158 5638 5639 O
) 158 159 5639 5640 O

Patients 0 8 5641 5649 O
with 9 13 5650 5654 O
incomplete 14 24 5655 5665 O
gross 25 30 5666 5671 O
resection 31 40 5672 5681 O
where 41 46 5682 5687 O
viable 47 53 5688 5694 O
GCT 54 57 5695 5698 B-clinical_variable
is 58 60 5699 5701 O
found 61 66 5702 5707 O
are 67 70 5708 5711 O
considered 71 81 5712 5722 O
eligible 82 90 5723 5731 O

Patients 0 8 5732 5740 O
with 9 13 5741 5745 O
newly 14 19 5746 5751 O
diagnosed 20 29 5752 5761 O
neuroblastoma 30 43 5762 5775 B-cancer
with 44 48 5776 5780 O
INSS 49 53 5781 5785 O
Stage 54 59 5786 5791 O
2A/2B 60 65 5792 5797 O
with 66 70 5798 5802 O
MYCN 71 75 5803 5807 B-clinical_variable
amplification 76 89 5808 5821 O
( 90 91 5822 5823 O
> 91 92 5823 5824 O
4 93 94 5825 5826 B-lower_bound
- 94 95 5826 5827 O
fold 95 99 5827 5831 O
increase 100 108 5832 5840 O
in 109 111 5841 5843 O
MYCN 112 116 5844 5848 O
signals 117 124 5849 5856 O
as 125 127 5857 5859 O
compared 128 136 5860 5868 O
to 137 139 5869 5871 O
reference 140 149 5872 5881 O
signals 150 157 5882 5889 O
) 157 158 5889 5890 O
, 158 159 5890 5891 O
regardless 160 170 5892 5902 O
of 171 173 5903 5905 O
age 174 177 5906 5909 O
or 178 180 5910 5912 O
additional 181 191 5913 5923 O
biologic 192 200 5924 5932 O
features 201 209 5933 5941 O

Patients 0 8 5942 5950 O
with 9 13 5951 5955 O
newly 14 19 5956 5961 O
diagnosed 20 29 5962 5971 O
neuroblastoma 30 43 5972 5985 B-cancer
with 44 48 5986 5990 O
INSS 49 53 5991 5995 B-cancer
Stage 54 59 5996 6001 I-cancer
3 60 61 6002 6003 I-cancer

Patients 0 8 6004 6012 O
with 9 13 6013 6017 O
newly 14 19 6018 6023 O
diagnosed 20 29 6024 6033 O
neuroblastoma 30 43 6034 6047 B-cancer
with 44 48 6048 6052 O
INSS 49 53 6053 6057 B-cancer
Stage 54 59 6058 6063 I-cancer
4 60 61 6064 6065 I-cancer
are 62 65 6066 6069 O
eligible 66 74 6070 6078 O

Patients 0 8 6079 6087 O
with 9 13 6088 6092 O
newly 14 19 6093 6098 O
diagnosed 20 29 6099 6108 O
neuroblastoma 30 43 6109 6122 B-cancer
with 44 48 6123 6127 O
INSS 49 53 6128 6132 B-clinical_variable
Stage 54 59 6133 6138 O
4S 60 62 6139 6141 B-lower_bound
with 63 67 6142 6146 O
MYCN 68 72 6147 6151 B-treatment
amplification 73 86 6152 6165 I-treatment
( 87 88 6166 6167 O
> 88 89 6167 6168 O
4 90 91 6169 6170 O
- 91 92 6170 6171 O
fold 92 96 6171 6175 O
increase 97 105 6176 6184 O
in 106 108 6185 6187 O
MYCN 109 113 6188 6192 O
expression 114 124 6193 6203 O
signals 125 132 6204 6211 O
as 133 135 6212 6214 O
compared 136 144 6215 6223 O
to 145 147 6224 6226 O
reference 148 157 6227 6236 O
signals 158 165 6237 6244 O
) 165 166 6244 6245 O
, 166 167 6245 6246 O
regardless 168 178 6247 6257 O
of 179 181 6258 6260 O
additional 182 192 6261 6271 O
biologic 193 201 6272 6280 O
features 202 210 6281 6289 O

Patients 0 8 6290 6298 O
≥ 9 10 6299 6300 O
365 11 14 6301 6304 B-lower_bound
days 15 19 6305 6309 I-lower_bound
initially 20 29 6310 6319 O
diagnosed 30 39 6320 6329 O
with 40 44 6330 6334 O
neuroblastoma 45 58 6335 6348 B-cancer
INSS 59 63 6349 6353 I-cancer
Stage 64 69 6354 6359 B-lower_bound
1 70 71 6360 6361 I-lower_bound
, 71 72 6361 6362 O
2 73 74 6363 6364 O
, 74 75 6364 6365 O
4S 76 78 6366 6368 B-upper_bound
who 79 82 6369 6372 O
progressed 83 93 6373 6383 O
to 94 96 6384 6386 O
aStage 97 103 6387 6393 O
4 104 105 6394 6395 O
without 106 113 6396 6403 O
interval 114 122 6404 6412 O
chemotherapy 123 135 6413 6425 B-treatment

Pregnant 0 8 6426 6434 B-pregnancy
or 9 11 6435 6437 O
breastfeeding 12 25 6438 6451 O

Primary 0 7 6452 6459 B-cancer
Malignant 8 17 6460 6469 I-cancer
Brain 18 23 6470 6475 I-cancer
Neoplasms 24 33 6476 6485 I-cancer
< 34 35 6486 6487 O
18 35 37 6487 6489 B-upper_bound
years 38 43 6490 6495 I-upper_bound
of 44 46 6496 6498 O
age 47 50 6499 6502 B-age
- 51 52 6503 6504 O
at 53 55 6505 6507 O
diagnosis 56 65 6508 6517 O
and/or 66 72 6518 6524 O
relapse 73 80 6525 6532 O

Pulmonary 0 9 6533 6542 O
: 9 10 6542 6543 O
oxygen 11 17 6544 6550 B-clinical_variable
saturation 18 28 6551 6561 I-clinical_variable
> 29 30 6562 6563 O
92 31 33 6564 6566 B-lower_bound
% 33 34 6566 6567 I-lower_bound
at 35 37 6568 6570 O
rest 38 42 6571 6575 O
( 43 44 6576 6577 O
on 44 46 6577 6579 O
room 47 51 6580 6584 O
air 52 55 6585 6588 O
) 55 56 6588 6589 O

Pulmonary 0 9 6590 6599 O
: 9 10 6599 6600 O
oxygen 11 17 6601 6607 B-clinical_variable
saturation 18 28 6608 6618 I-clinical_variable
> 29 30 6619 6620 O
94 31 33 6621 6623 B-lower_bound
% 33 34 6623 6624 I-lower_bound
at 35 37 6625 6627 O
rest 38 42 6628 6632 O
( 43 44 6633 6634 O
on 44 46 6634 6636 O
room 47 51 6637 6641 O
air 52 55 6642 6645 O
) 55 56 6645 6646 O

Renal 0 5 6647 6652 B-cancer
Tumors 6 12 6653 6659 I-cancer
- 13 14 6660 6661 O
relapsed 15 23 6662 6670 O
( 24 25 6671 6672 O
all 25 28 6672 6675 O
histology 29 38 6676 6685 O
- 39 40 6686 6687 O
Wilm 41 45 6688 6692 B-cancer
's 45 47 6692 6694 I-cancer
tumor 48 53 6695 6700 I-cancer
) 53 54 6700 6701 O
or 55 57 6702 6704 O
at 58 60 6705 6707 O
diagnosis 61 70 6708 6717 O
( 71 72 6718 6719 O
clear 72 77 6719 6724 B-cancer
cell 78 82 6725 6729 I-cancer
sarcoma 83 90 6730 6737 I-cancer
and 91 94 6738 6741 O
Rhabdoid 95 103 6742 6750 B-cancer
tumor 104 109 6751 6756 I-cancer
) 109 110 6756 6757 O

Renal 0 5 6758 6763 O
: 5 6 6763 6764 O
Creatinine 7 17 6765 6775 B-clinical_variable
clearance 18 27 6776 6785 I-clinical_variable
or 28 30 6786 6788 O
GFR 31 34 6789 6792 B-clinical_variable
> 35 36 6793 6794 O
60 37 39 6795 6797 B-lower_bound
ml 40 42 6798 6800 I-lower_bound
/ 42 43 6800 6801 I-lower_bound
min/1.73m2 43 53 6801 6811 I-lower_bound
( 54 55 6812 6813 O
If 55 57 6813 6815 O
a 58 59 6816 6817 O
creatinine 60 70 6818 6828 B-clinical_variable
clearance 71 80 6829 6838 I-clinical_variable
is 81 83 6839 6841 O
performed 84 93 6842 6851 O
at 94 96 6852 6854 O
end 97 100 6855 6858 O
of 101 103 6859 6861 O
induction 104 113 6862 6871 O
and 114 117 6872 6875 O
the 118 121 6876 6879 O
result 122 128 6880 6886 O
is 129 131 6887 6889 O
< 132 133 6890 6891 O
100 134 137 6892 6895 B-upper_bound
ml 138 140 6896 6898 I-upper_bound
/ 140 141 6898 6899 I-upper_bound
min/1.73m2 141 151 6899 6909 I-upper_bound
, 151 152 6909 6910 O
a 153 154 6911 6912 O
GFR 155 158 6913 6916 O
must 159 163 6917 6921 O
be 164 166 6922 6924 O
performed 167 176 6925 6934 O
using 177 182 6935 6940 O
a 183 184 6941 6942 O
nuclear 185 192 6943 6950 O
blood 193 198 6951 6956 O
sampling 199 207 6957 6965 O
method 208 214 6966 6972 O
or 215 217 6973 6975 O
iothalamate 218 229 6976 6987 O
clearance 230 239 6988 6997 O
method 240 246 6998 7004 O

Renal 0 5 7005 7010 O
: 5 6 7010 7011 O
GFR 7 10 7012 7015 B-clinical_variable
≥ 11 12 7016 7017 O
50 13 15 7018 7020 B-lower_bound
ml 16 18 7021 7023 I-lower_bound
/ 18 19 7023 7024 I-lower_bound
min/1.73m2 19 29 7024 7034 I-lower_bound

Renal 0 5 7035 7040 O
: 5 6 7040 7041 O
GFR 7 10 7042 7045 B-clinical_variable
≥ 11 12 7046 7047 O
50 13 15 7048 7050 B-lower_bound
ml 16 18 7051 7053 I-lower_bound
/ 18 19 7053 7054 I-lower_bound
min/1.73m2 19 29 7054 7064 I-lower_bound
or 30 32 7065 7067 O
serum 33 38 7068 7073 B-clinical_variable
creatinine 39 49 7074 7084 I-clinical_variable
≤ 50 51 7085 7086 O
2.5 52 55 7087 7090 B-upper_bound
x 56 57 7091 7092 I-upper_bound
ULN 58 61 7093 7096 B-clinical_variable
for 62 65 7097 7100 O
age 66 69 7101 7104 B-age

Retinoblastoma 0 14 7105 7119 B-cancer
- 15 16 7120 7121 O
disseminated 17 29 7122 7134 O
at 30 32 7135 7137 O
diagnosis 33 42 7138 7147 O
and/or 43 49 7148 7154 O
relapsed 50 58 7155 7163 O

Rhabdomyosarcoma 0 16 7164 7180 B-cancer
- 17 18 7181 7182 O
metastatic 19 29 7183 7193 O
at 30 32 7194 7196 O
time 33 37 7197 7201 O
of 38 40 7202 7204 O
diagnosis 41 50 7205 7214 O
and/or 51 57 7215 7221 O
relapsed 58 66 7222 7230 O
after 67 72 7231 7236 O
therapy 73 80 7237 7244 B-treatment

Soft 0 4 7245 7249 B-cancer
Tissue 5 11 7250 7256 I-cancer
Sarcoma 12 19 7257 7264 I-cancer
- 20 21 7265 7266 O
chemotherapy 22 34 7267 7279 O
responsive 35 45 7280 7290 O
metastatic 46 56 7291 7301 B-chronic_disease
disease 57 64 7302 7309 I-chronic_disease
or 65 67 7310 7312 O
chemotherapy 68 80 7313 7325 O
responsive 81 91 7326 7336 O
relapsed 92 100 7337 7345 O
disease 101 108 7346 7353 O

Supra 0 5 7354 7359 B-cancer
- 5 6 7359 7360 I-cancer
tentorial 6 15 7360 7369 I-cancer
Primative 16 25 7370 7379 I-cancer
Neuro 26 31 7380 7385 I-cancer
- 31 32 7385 7386 I-cancer
Ectodermal 32 42 7386 7396 I-cancer
Tumor 43 48 7397 7402 I-cancer
( 49 50 7403 7404 I-cancer
PNET 50 54 7404 7408 I-cancer
) 54 55 7408 7409 I-cancer

This 0 4 7410 7414 O
would 5 10 7415 7420 O
require 11 18 7421 7428 O
a 19 20 7429 7430 O
clinical 21 29 7431 7439 O
situation 30 39 7440 7449 O
consistent 40 50 7450 7460 O
with 51 55 7461 7465 O
the 56 59 7466 7469 O
diagnosis 60 69 7470 7479 O
of 70 72 7480 7482 O
GCT 73 76 7483 7486 B-cancer
( 77 78 7487 7488 O
testicular 78 88 7488 7498 B-cancer
, 88 89 7498 7499 O
peritoneal 90 100 7500 7510 B-cancer
, 100 101 7510 7511 O
retroperitoneal 102 117 7512 7527 B-cancer
or 118 120 7528 7530 O
mediastinal 121 132 7531 7542 B-cancer
mass 133 137 7543 7547 I-cancer
, 137 138 7547 7548 O
elevated 139 147 7549 7557 B-clinical_variable
tumor 148 153 7558 7563 I-clinical_variable
marker 154 160 7564 7570 I-clinical_variable
levels 161 167 7571 7577 I-clinical_variable
{ 168 169 7578 7579 O
HCG 169 172 7579 7582 B-clinical_variable
≥ 173 174 7583 7584 O
500 175 178 7585 7588 B-lower_bound
; 178 179 7588 7589 O
AFP 180 183 7590 7593 B-clinical_variable
≥ 184 185 7594 7595 O
500 186 189 7596 7599 O
} 189 190 7599 7600 O
and 191 194 7601 7604 O
typical 195 202 7605 7612 O
pattern 203 210 7613 7620 O
of 211 213 7621 7623 O
metastases 214 224 7624 7634 B-cancer
) 224 225 7634 7635 O

Timing 0 6 7636 7642 O
: 6 7 7642 7643 O
Recovery 8 16 7644 7652 O
from 17 21 7653 7657 O
last 22 26 7658 7662 O
induction 27 36 7663 7672 O
course 37 43 7673 7679 O
of 44 46 7680 7682 O
chemotherapy 47 59 7683 7695 B-treatment

Timing 0 6 7696 7702 O
: 6 7 7702 7703 O
patients 8 16 7704 7712 O
must 17 21 7713 7717 O
be 22 24 7718 7720 O
fully 25 30 7721 7726 O
recovered 31 40 7727 7736 O
from 41 45 7737 7741 O
radiation 46 55 7742 7751 B-treatment
, 55 56 7751 7752 O
induction 57 66 7753 7762 B-treatment
chemotherapy 67 79 7763 7775 I-treatment
or 80 82 7776 7778 O
surgery 83 90 7779 7786 B-treatment
prior 91 96 7787 7792 I-treatment
to 97 99 7793 7795 O
receiving 100 109 7796 7805 O
consolidation 110 123 7806 7819 B-treatment
, 123 124 7819 7820 O
with 125 129 7821 7825 O
minimum 130 137 7826 7833 O
elapsed 138 145 7834 7841 O
time 146 150 7842 7846 O
of 151 153 7847 7849 O
2 154 155 7850 7851 B-lower_bound
weeks 156 161 7852 7857 I-lower_bound

Tumor 0 5 7858 7863 B-treatment
biopsy 6 12 7864 7870 I-treatment
of 13 15 7871 7873 O
new 16 19 7874 7877 O
or 20 22 7878 7880 O
growing 23 30 7881 7888 O
or 31 33 7889 7891 O
unresectable 34 46 7892 7904 O
lesions 47 54 7905 7912 O
demonstrating 55 68 7913 7926 O
viable 69 75 7927 7933 O
non 76 79 7934 7937 B-cancer
- 79 80 7937 7938 I-cancer
teratomatous 80 92 7938 7950 I-cancer
GCT 93 96 7951 7954 I-cancer

Tumor 0 5 7955 7960 B-cancer
may 6 9 7961 7964 O
have 10 14 7965 7969 O
originated 15 25 7970 7980 O
in 26 28 7981 7983 O
any 29 32 7984 7987 O
primary 33 40 7988 7995 O
site 41 45 7996 8000 O

ardiac 0 6 8001 8007 B-chronic_disease
: 6 7 8007 8008 O
Shortening 8 18 8009 8019 B-clinical_variable
fraction 19 27 8020 8028 I-clinical_variable
≥ 28 29 8029 8030 O
27 30 32 8031 8033 B-lower_bound
% 32 33 8033 8034 I-lower_bound
, 33 34 8034 8035 O
or 35 37 8036 8038 O
ejection 38 46 8039 8047 B-clinical_variable
fraction 47 55 8048 8056 I-clinical_variable
≥ 56 57 8057 8058 O
50 58 60 8059 8061 B-lower_bound
% 60 61 8061 8062 I-lower_bound
, 61 62 8062 8063 O
no 63 65 8064 8066 O
clinical 66 74 8067 8075 O
congestive 75 85 8076 8086 B-chronic_disease
heart 86 91 8087 8092 I-chronic_disease
failure 92 99 8093 8100 I-chronic_disease

extraneural 0 11 8101 8112 B-cancer
metastases 12 22 8113 8123 I-cancer
, 22 23 8123 8124 I-cancer
M4 24 26 8125 8127 I-cancer

gross 0 5 8128 8133 O
nodular 6 13 8134 8141 O
seeding 14 21 8142 8149 O
in 22 24 8150 8152 O
the 25 28 8153 8156 O
intracranial 29 41 8157 8169 O
subarachnoid 42 54 8170 8182 O
space 55 60 8183 8188 O
or 61 63 8189 8191 O
ventricular 64 75 8192 8203 O
system 76 82 8204 8210 O
distant 83 90 8211 8218 O
from 91 95 8219 8223 O
primary 96 103 8224 8231 O
tumor 104 109 8232 8237 B-cancer
site 110 114 8238 8242 O
, 114 115 8242 8243 O
M2 116 118 8244 8246 O

lumbar 0 6 8247 8253 O
CSF 7 10 8254 8257 O
cytology 11 19 8258 8266 O
positive 20 28 8267 8275 O
for 29 32 8276 8279 O
tumor 33 38 8280 8285 O
cells 39 44 8286 8291 O
by 45 47 8292 8294 O
analysis 48 56 8295 8303 O
of 57 59 8304 8306 O
fluid 60 65 8307 8312 O
collected 66 75 8313 8322 O
either 76 82 8323 8329 O
before 83 89 8330 8336 O
definitive 90 100 8337 8347 B-treatment
surgery 101 108 8348 8355 I-treatment
or 109 111 8356 8358 O
at 112 114 8359 8361 O
least 115 120 8362 8367 O
10 121 123 8368 8370 B-lower_bound
days 124 128 8371 8375 I-lower_bound
after 129 134 8376 8381 O
definitive 135 145 8382 8392 O
surgery 146 153 8393 8400 O

patients 0 8 8401 8409 O
must 9 13 8410 8414 O
not 14 17 8415 8418 O
be 18 20 8419 8421 O
in 21 23 8422 8424 O
status 24 30 8425 8431 B-chronic_disease
epilepticus 31 42 8432 8443 I-chronic_disease
, 42 43 8443 8444 O
coma 44 48 8445 8449 O
or 49 51 8450 8452 O
require 52 59 8453 8460 O
assisted 60 68 8461 8469 B-treatment
ventilation 69 80 8470 8481 I-treatment

stable 0 6 8482 8488 O
, 6 7 8488 8489 O
non 8 11 8490 8493 O
- 11 12 8493 8494 O
progressive 12 23 8494 8505 O
disease 24 31 8506 8513 O
( 32 33 8514 8515 O
defined 33 40 8515 8522 O
as 41 43 8523 8525 O
non 44 47 8526 8529 O
- 47 48 8529 8530 O
progressive 48 59 8530 8541 O
abnormalities 60 73 8542 8555 O
on 74 76 8556 8558 O
physical 77 85 8559 8567 O
exam 86 90 8568 8572 O
or 91 93 8573 8575 O
CT 94 96 8576 8578 B-treatment
and/or 97 103 8579 8585 O
MRI 104 107 8586 8589 B-treatment
) 107 108 8589 8590 O
within 109 115 8591 8597 O
4 116 117 8598 8599 B-upper_bound
weeks 118 123 8600 8605 I-upper_bound
of 124 126 8606 8608 O
study 127 132 8609 8614 O
entry 133 138 8615 8620 O

